Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Targeted oncogene activation by site-specific recombination in transgenic mice.

http://www.ncbi.nlm.nih.gov/pubmed/1631115

An efficient and accurate method for controlled in vivo transgene modulation by site-directed recombination is described. Seven transgenic mouse founder lines were produced carrying the murine lens-specific alpha A-crystallin promoter and the simian virus 40 large tumor-antigen gene sequence, separated by a 1.3-kilobase-pair Stop sequence that contains elements preventing expression of the large tumor-antigen gene and Cre recombinase recognition sites. Progeny from two of these lines were mated with transgenic mice expressing the Cre recombinase under control of either the murine alpha A-crystallin promoter or the human cytomegalovirus promoter. All double-transgenic offspring developed lens tumors. Subsequent analysis confirmed that tumor formation resulted from large tumor-antigen activation via site-specific, Cre-mediated deletion of Stop sequences.

Pubmed ID: 1631115 RIS Download

Mesh terms: Animals | Antigens, Polyomavirus Transforming | Base Sequence | Cataract | DNA Nucleotidyltransferases | Eye Neoplasms | Integrases | Mice | Mice, Transgenic | Molecular Sequence Data | Oligodeoxyribonucleotides | Oncogenes | Recombination, Genetic | Regulatory Sequences, Nucleic Acid | Viral Proteins